Businesstoday
HOME
ECONOMY
Divert oxygen from industries to save lives, Delhi HC orders Centre
Keep border issue at 'appropriate position', focus on long term ties: China to India
7,500 MT oxygen being produced daily, 6,600 MT allocated to states for medical use: Govt
CARE Ratings cuts India's GDP forecast to 10.2% for FY22
600% jump in oxygen demand from hospitals
CORPORATE
6 lakh carts were waiting to check out during PM Modi's speech, reveals Grofers CEO
Cutis Biotech claims 'Covishield' over prior use; Bombay HC says 'No', will cause confusion
Reliance ramps up daily oxygen output to over 700 tonnes
Nestle net profit rises 14.62% to Rs 602.25 crore in Mar quarter
After stellar growth FY21, Firefox Bikes eyes another bumper year
MARKETS
Oil prices plummet on rising COVID-19 cases in India; Brent crude reaches $66.09 per barrel
Stock market shut today due to Ram Navami, trading to resume on Thursday
Cryptocurrency inflows reach $4.9 billion on April 16
COVID-19: Bombay Oxygen shares up 256%; it doesn't even make oxygen
'Oxygen' rally in stock market: Name enough to lift shares in Covid-era
MONEY
COVID second wave shaves 10% off Sensex; more downside ahead?
IndiaFirst Life Insurance raises term plan premium by 25% in first-ever hike
National Pension System: PFRDA makes 5 key announcements
MFIs to face asset quality pressures in near term due to recent surge in COVID-19 cases: Icra
COVID-19 impact: Expect 15% hike in health insurance premium by next quarter
INDUSTRY
Hero Motocorp to develop EVs, set up battery swapping stations with Taiwan's Gogoro
SII's Covishield comprises over 90% of 12.76 crore COVID-19 vaccines administered so far
COVAXIN effective against UK, Brazil variants of SARS-CoV-2: ICMR
Discoms' overdues fall to Rs 74,510 crore in March
Custom duty on Remdesivir injections, raw materials waived
TECH
Apex Legends Mobile beta to be available in India first, global rollout to follow later
Apple reminds app developers to adhere to its new App Tracking Transparency rules ahead of iOS 14.5 rollout
Elon Musk could not get a job in 1995, now he has responded to it
Oppo K9 launch set for May 6, teaser reveals 65W fast charging and 64-megapixel camera
Realme 8 5G India launch tomorrow, price, specifications, and everything else you can expect
OPINION
Can a global minimum corporate tax be a game-changer for India?
India's e-payments space: A dawn or down of retail in India?
How Millennials, Gen Z are shifting focus to balance in work life, not just work-life balance
WhatsApp leak case: Do companies need to root out the mole within
India badly needs Sputnik V in fight against COVID-19
photos
Covid-19 vaccine for above 18 years: How celebs reacted
Record high rabi foodgrain output during 2020-21
Emotional scenes at airport as New Zealand-Australia travel bubble opens
India's merchandise exports see 7.3% de-growth in FY21
10 reasons why new research suggests that coronavirus is airborne
Videos
02:20
Covaxin effective against India's double mutant strain
04:18
PM Modi applauds vaccine makers, says lockdown last resort
03:26
Chidambaram slams new vaccine policy; Sitharaman on economy revival
05:27
Nashik: 22 dead as oxygen leaks from tanker outside Maharashtra hospital
03:15
New COVID variant hitting children hard as India reels under 2nd wave
MAGAZINE
May 2, 2021
April 18, 2021
April 4, 2021
March 21, 2021
March 7, 2021
Settings
Logout
BT SPECIALS
UNION BUDGET
SPECIAL ISSUES
SPECIAL REPORTS
BT BUZZ
SLOWDOWN BLUES
JOBS REALITY CHECK
WORLD ECONOMIC FORUM
LOK SABHA ELECTION 2019
REBRAIN OR ROT
EVENTS
MAGAZINE ARCHIVES
BUSINESS TODAY
MONEY TODAY
GADGETS AND GIZMOS
Home
Search
Total 264 results found. Search for
[ COVID-19 vaccine China trials ]
Results 1 to 21 of 264
China mulls mixing COVID-19 vaccines to 'optimise' production
Reuters
April 12, 2021
The currently available vaccines \"don't have very high rates of protection\", said Gao Fu, the director of the Chinese Centers for Disease Control and Prevention
Bengaluru's Stelis Biopharma to produce 200 million doses of Russia's Sputnik V COVID-19 vaccine
BusinessToday.In
March 19, 2021
Stelis and the RDIF plan to start supplying the vaccine doses in the third quarter of this year, said Strides Pharma. It is yet to be ascertained which countries the doses would go to
Germany, Italy, France suspend AstraZeneca COVID-19 vaccine amid safety fears
Reuters
March 16, 2021
The moves by some of Europe's largest and most populous countries will deepen concerns about the slow rollout of vaccines in the region, which has been plagued by shortages due to problems producing vaccines, including AstraZeneca's
Countries should be able to make their own political choices: PM Modi, Biden, Morrison, Suga in joint op-ed
PTI
March 14, 2021
After holding the first Leaders' Summit of Quadrilateral alliance on Friday, Prime Minister Narendra Modi, US President Joe Biden, Australian PM Scott Morrison and Japanese PM Yoshihide Suga wrote a opinion piece in The Washington Post
China aims to vaccinate 70-80% of population by mid-2022
Associated Press
March 13, 2021
Although emergency vaccinations have been underway in China since at least last summer, the country has been slow to announce whether it had any plans to achieve herd immunity
Pfizer wants to make vaccine in India; seeks assurance on faster clearance, export freedom
Reuters
March 10, 2021
The US company pulled an application last month seeking emergency approval for its product in India after the drug regulator declined its request to skip a small local safety trial. That has kept its vaccine, developed with Germany's BioNTech SE, out of one of the world's biggest drug markets
Covaxin safe, immunogenic with no side effects, says Lancet
Rashi Bisaria
New Delhi, March 10, 2021
Covaxin safe, immunogenic with no side effects, says Lancet Medical peer-review journal Lancet has published the interim results for phase 2 trials of Bharat Biotech's COVID-19 vaccine, Covaxin, calling it 'safe, immunogenic with no serious side effects'. The double-blind, randomised, multicentre, phase 2 clinical trial to evaluate the immunogenicity and safety of Covaxin (BBV152) in healthy adults and adolescents (aged 12-65 years) was carried out at nine hospitals in India. Data breach c...
COVID-19 vaccine: Italy first EU country to produce Sputnik V
Associated Press
March 10, 2021
Sputnik V has not yet been approved for use in the EU, but the body's regulator, the European Medicines Agency, started a rolling review of the vaccine last week
China rolls out first single dose COVID-19 vaccine
PTI
February 28, 2021
China has given conditional approval for a single dose COVID-19 vaccine, touted to be a rival to Johnson & Johnson's one-jab shot cleared by the US drug regulator
More COVID-19 vaccines on the way; Serum, Dr Reddy's, Biological E in advanced stages
BusinessToday.In
February 24, 2021
Biological E has tied up with vaccine maker Johnson & Johnson and Baylor College of Medicine in Houston. And, it plans to start the Phase 3 trial of the candidate licensed from Baylor College next week
Sanofi's COVID-19 vaccine not ready in 2021, says CEO
Reuters
February 14, 2021
In December last year, Sanofi had said it was targeting \"earliest potential approval\" of the shot in the second half of 2021, following positive preclinical data
Sputnik V delivers 91.6% efficacy; Jack Ma delisted from business leaders list
BusinessToday.In
New Delhi, February 3, 2021
Russia's COVID-19 vaccine, Sputnik V, has shown 91.6 per cent efficacy in phase 3 trials with no serious side effects, as per an interim analysis published in The Lancet Journal; Oxford Languages has named 'Aatmanirbharta' as its Hindi Word of the Year 2020; Alibaba Group founder Jack Ma has been delisted from \"Chinese entrepreneurial leaders\" list published by the country's official state media. Watch this and more on News Blast. Also Read: RBI releases framework for risk-based internal audit of NBFCs, UCBs
Russia's Sputnik V vaccine shows 91.6% efficacy in phase 3 trials: Lancet
BusinessToday.In
February 2, 2021
The Gam-COVID-Vac, called Sputnik V, is a two-part vaccine that includes two adenovirus vectors - recombinant human adenovirus type 26 (rAd26-S) and recombinant human adenovirus type 5 (rAd5-S).
COVID-19 vaccine: AstraZeneca's China partner expects to produce 400 million doses a year
Reuters
February 2, 2021
The firm obtained rights to supply the AZD1222 vaccine, developed by the Anglo-Swedish drugmaker and Oxford University, in mainland China last year in return for having capacity to produce at least 200 million doses by the end of 2021
Chinese COVID-19 tests maker worked with PLA: report
Reuters
January 30, 2021
The review, of more than 40 publicly available documents and research papers in Chinese and English, shows BGI's links to the People's Liberation Army (PLA) include research with China's top military supercomputing experts
Reliance signs $15 million deal with Israeli firm for rapid COVID-19 test kits
BusinessToday.In
January 27, 2021
The Reliance Group will purchase hundreds of COVID-19 breath testing system from the Israeli company for $15 million. The group will use them to conduct millions of tests at a cost of $10 million per month
Don't worry! 63 COVID-19 vaccines in pipeline, another 173 in the works
PB Jayakumar
January 27, 2021
COVID-19 vaccine: About 19 vaccines are going to be globally available in the coming few weeks and months. Of this, about nine have already got emergency use authorisation
Coronavirus vaccine: Pakistan approves AstraZeneca vaccine for emergency use
Reuters
January 17, 2021
COVID-19 vaccine: Pakistan, which is seeing rising numbers of coronavirus infections, said its vaccines would be procured from multiple sources
Four more COVID-19 vaccines on cards in India, check prices here
BusinessToday.In
January 12, 2021
Among these vaccines are those developed by Zydus Cadila, Biological E and Gennova, along with Russia's Sputnik-V vaccine
Stocks in news: GAIL, Tata Motors, Dr Reddy, M&M, HUL, Force Motors, Sunteck Realty
BusinessToday.In
January 12, 2021
Stocks to watch today on January 12: GAIL, Tata Motors, Dr Reddy, M&M, HUL, Force Motors, Sunteck Realty among others are the top stocks to watch out for in Tuesday's trading session
PAGES 1 OF 14
1
2
3
4
5
Advertisement
LATEST
Must Read
TECH NEWS
Divert oxygen from industries to save lives, Delhi HC orders Centre
Keep border issue at 'appropriate position', focus on long term ties: China to India
More farmers joining protest at Delhi borders: Samyukta Kisan Morcha
7,500 MT oxygen being produced daily, 6,600 MT allocated to states for medical use: Govt
Free vaccination to all aged above 18, says Bihar CM
More
Reliance Jio Prime vs Airtel, Vodafone, Idea 4G offers
Reliance Jio plans to bring 5G internet to your smartphones
Maruti Suzuki opens online booking for Baleno RS
India Inc to get 9.5 per cent salary hike this year
Five tips to get a good salary hike this year
Apex Legends Mobile beta to be available in India first, global rollout to follow later
Apple reminds app developers to adhere to its new App Tracking Transparency rules ahead of iOS 14.5 rollout
Oppo K9 launch set for May 6, teaser reveals 65W fast charging and 64-megapixel camera
Elon Musk could not get a job in 1995, now he has responded to it
Realme 8 5G India launch tomorrow, price, specifications, and everything else you can expect
More